Guido Baechler - 13 Feb 2026 Form 4 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: MYNZ
Reported as of: 13 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 17:15:24 UTC
Prior SEC filing: 26 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Guido Baechler

Key filing fact

Guido Baechler filed Form 4 for MAINZ BIOMED N.V. (MYNZ) on 19 Feb 2026.

Key facts

This page summarizes Guido Baechler's Form 4 filing for MAINZ BIOMED N.V. (MYNZ).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 17:15.

Change

Previous filing in this sequence was filed on 26 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001561662 Primary reporting owner

BAECHLER GUIDO

Relationship: Chief Executive Officer, Director
Address: MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ
Signature: /s/ Guido Baechler
Signature date: 19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYNZ transaction

Ordinary Shares

Award

Transaction value: $0
Shares: +440,000
Change %: +267%
Price: $0.000000
Shares after: 605,058
Date: 13 Feb 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid.

Footnote F2

6,362 ordinary shares held, and 158,696 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .